However, attempts to generate animal models for β2-m associated diseases have stalled as, in spite of good levels of expression of β2-m in transgenic mice expressing the wild type4 protein or the pathogenic variant D76N, no pathological phenotype of β2-m amyloidosis has been observed. This evidence concerns the gene B2M and amyloidosis.